Lista de obras - K Toth - Dominio Público Uruguay

A fully replication-competent adenovirus vector with enhanced oncolytic properties

artículo científico publicado en 2010

A multitasking oncolytic adenovirus vector

article

Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice.

artículo científico publicado en 2005

Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc)

scientific article published on 01 August 2002

Adenovirus vectors for gene therapy, vaccination and cancer gene therapy

artículo científico publicado en 2013

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters.

artículo científico publicado en 2017

Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9.

artículo científico publicado en 2018

Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model

artículo científico publicado en 2014

Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.

artículo científico publicado en 2017

Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region

artículo científico publicado en 2002

Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

artículo científico publicado en 2005

Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters

artículo científico publicado en 2014

Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.

artículo científico publicado en 2014

Generation and characterization of an IL2RG knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients

artículo científico publicado en 2020

HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.

artículo científico publicado en 2017

HEK? No!

artículo científico publicado en 2002

INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.

artículo científico publicado en 2009

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

artículo científico publicado en 1999

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

artículo científico publicado en 2008

Increasing the Efficacy of Oncolytic Adenovirus Vectors ⬇️

artículo científico publicado el 27 de agosto de 2010

Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females.

artículo científico publicado en 2017

New drug on the horizon for treating adenovirus

artículo científico publicado en 2015

New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.

artículo científico publicado en 2009

Oncolytic (replication-competent) adenoviruses as anticancer agents.

artículo científico publicado en 2010

Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus

article

Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model

artículo científico publicado en 2009

STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control

artículo científico publicado en 2015

Specific recruitment of γδ regulatory T cells in human breast cancer.

artículo científico publicado en 2013

Syrian Hamster Tumor Model to Study Oncolytic Ad5-Based Vectors ⬇️

artículo científico publicado el 1 de enero de 2012

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

artículo científico publicado en 2006

Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.

artículo científico publicado en 1995

Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.

artículo científico publicado en 2015

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

artículo científico publicado en 2000

Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters

artículo científico publicado en 2015

miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling ⬇️

artículo científico publicado el 8 de marzo de 2012

Lista de obras de K Toth

A fully replication-competent adenovirus vector with enhanced oncolytic properties

A multitasking oncolytic adenovirus vector

Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice.

Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc)

Adenovirus vectors for gene therapy, vaccination and cancer gene therapy

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters.

Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9.

Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model

Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.

Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region

Cotton rat tumor model for the evaluation of oncolytic adenoviruses.

Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters

Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.

Generation and characterization of an IL2RG knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients

HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.

HEK? No!

INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.

Increasing the Efficacy of Oncolytic Adenovirus Vectors ⬇️

Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females.

New drug on the horizon for treating adenovirus

New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.

Oncolytic (replication-competent) adenoviruses as anticancer agents.

Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus

Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model

STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control

Specific recruitment of γδ regulatory T cells in human breast cancer.

Syrian Hamster Tumor Model to Study Oncolytic Ad5-Based Vectors ⬇️

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.

Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters

miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling ⬇️